(Total Views: 557)
Posted On: 02/26/2021 11:25:39 AM
Post# of 154725
FWIW I think CYDY likely has what it needs at 28 days and will set a new standard. We will find out eventually.
IMO Nader's decision to not do the 75% review & to not add the 42 days observation to the official protocol (to the best of my knowledge) also may have been strategic in a way I haven't seen mentioned. He may have realized that by NOT extending the observation period, he gives other drugs some limited ability to compare to a SOC without Leronlimab in s/c cases.
Part of me thinks this plays politics a little, but results in changing more hearts & minds at the FDA which leads to more respect with other trials.
JMO
IMO Nader's decision to not do the 75% review & to not add the 42 days observation to the official protocol (to the best of my knowledge) also may have been strategic in a way I haven't seen mentioned. He may have realized that by NOT extending the observation period, he gives other drugs some limited ability to compare to a SOC without Leronlimab in s/c cases.
Part of me thinks this plays politics a little, but results in changing more hearts & minds at the FDA which leads to more respect with other trials.
JMO
(3)
(0)
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.
